CO5251423A1 - Tratamiento de endometriosis o infertilidad, o mejora de la fertilidad - Google Patents

Tratamiento de endometriosis o infertilidad, o mejora de la fertilidad

Info

Publication number
CO5251423A1
CO5251423A1 CO00075387A CO00075387A CO5251423A1 CO 5251423 A1 CO5251423 A1 CO 5251423A1 CO 00075387 A CO00075387 A CO 00075387A CO 00075387 A CO00075387 A CO 00075387A CO 5251423 A1 CO5251423 A1 CO 5251423A1
Authority
CO
Colombia
Prior art keywords
infertility
fertility
endometriosis
improvement
treatment
Prior art date
Application number
CO00075387A
Other languages
English (en)
Spanish (es)
Inventor
William J Bologna
Dominique De Ziegler
Howard L Levine
Original Assignee
Columbia Lab Bermuda Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia Lab Bermuda Ltd filed Critical Columbia Lab Bermuda Ltd
Publication of CO5251423A1 publication Critical patent/CO5251423A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CO00075387A 1999-10-05 2000-10-04 Tratamiento de endometriosis o infertilidad, o mejora de la fertilidad CO5251423A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15775499P 1999-10-05 1999-10-05
US66838400A 2000-09-25 2000-09-25

Publications (1)

Publication Number Publication Date
CO5251423A1 true CO5251423A1 (es) 2003-02-28

Family

ID=26854456

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00075387A CO5251423A1 (es) 1999-10-05 2000-10-04 Tratamiento de endometriosis o infertilidad, o mejora de la fertilidad

Country Status (28)

Country Link
EP (1) EP1220667B1 (https=)
JP (2) JP2003510354A (https=)
KR (1) KR100738724B1 (https=)
CN (1) CN1218694C (https=)
AR (1) AR028487A1 (https=)
AT (1) ATE271860T1 (https=)
AU (1) AU780736B2 (https=)
BR (1) BR0014548A (https=)
CA (1) CA2385974C (https=)
CO (1) CO5251423A1 (https=)
DE (1) DE60012554T2 (https=)
DK (1) DK1220667T3 (https=)
ES (1) ES2223581T3 (https=)
GE (1) GEP20043313B (https=)
HK (1) HK1044120B (https=)
HU (1) HU225990B1 (https=)
IL (2) IL148784A0 (https=)
MA (1) MA25501A1 (https=)
MX (1) MXPA02003453A (https=)
MY (1) MY129518A (https=)
NO (1) NO329663B1 (https=)
NZ (1) NZ518429A (https=)
PE (1) PE20010742A1 (https=)
PT (1) PT1220667E (https=)
TR (1) TR200200899T2 (https=)
TW (1) TWI280877B (https=)
UA (1) UA74168C2 (https=)
WO (1) WO2001024788A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
CN101327326A (zh) * 2001-10-29 2008-12-24 哥伦比亚实验室(百慕大群岛)有限公司 阴道给药治疗骨盆痛和不孕症的抗节律障碍剂
ES2237298B1 (es) 2003-07-16 2006-11-01 Italfarmaco, S.A. Formulaciones mucoadhesivas semisolidas.
EP1872775A1 (en) 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
ES2344673B1 (es) 2008-08-07 2011-05-03 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farmaceutica parael tratamiento de atrofia vaginal en mujeres con riesgo de potologiatumoral.
ES2344675B1 (es) 2008-12-19 2011-04-28 Italfarmaco, S.A. Uso de estriol en la preparacion de una formulacion farrmaceutica para el tratamiento de atrofia vaginal en mujeres con riesgo de patologiacardiovascular.
EP3865502A1 (en) * 2010-03-22 2021-08-18 Allergan Pharmaceuticals International Limited Compositions and methods for non-toxic delivery of cdb-2914
KR101010031B1 (ko) * 2010-12-08 2011-01-21 류상범 흡수식 냉온수기용 엘리미네이터
SG11201407397WA (en) 2012-05-31 2014-12-30 Repros Therapeutics Inc Formulations and methods for vaginal delivery of antiprogestins
ES2688821T3 (es) 2012-11-02 2018-11-07 Repros Therapeutics Inc. Métodos y composiciones para tratar afecciones dependientes de la progesterona

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241087A (en) * 1979-04-02 1980-12-23 William H. Rorer, Inc. Dysmenorrhea treatment
NZ232801A (en) * 1989-03-07 1992-01-29 Adeza Biomedical Corp Diagnostic test for endometriosis
JP2602456B2 (ja) * 1990-04-12 1997-04-23 雪印乳業株式会社 子宮内膜症治療剤
IT1251114B (it) * 1991-07-26 1995-05-04 Farcon Ag Forme farmaceutiche antivirali per applicazione vaginale
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen

Also Published As

Publication number Publication date
ES2223581T3 (es) 2005-03-01
GEP20043313B (en) 2004-03-10
AU7525000A (en) 2001-05-10
JP2010018639A (ja) 2010-01-28
DE60012554D1 (de) 2004-09-02
PT1220667E (pt) 2004-11-30
TWI280877B (en) 2007-05-11
UA74168C2 (uk) 2005-11-15
IL148784A (en) 2006-12-31
DK1220667T3 (da) 2004-12-06
HK1044120B (en) 2004-12-17
ATE271860T1 (de) 2004-08-15
AU780736B2 (en) 2005-04-14
WO2001024788A2 (en) 2001-04-12
NO20021591D0 (no) 2002-04-04
BR0014548A (pt) 2002-06-04
DE60012554T2 (de) 2005-11-24
MY129518A (en) 2007-04-30
NO329663B1 (no) 2010-11-29
NZ518429A (en) 2004-02-27
KR20020062285A (ko) 2002-07-25
CN1218694C (zh) 2005-09-14
HUP0203050A3 (en) 2006-02-28
NO20021591L (no) 2002-05-28
HK1044120A1 (en) 2002-10-11
EP1220667A2 (en) 2002-07-10
IL148784A0 (en) 2002-09-12
WO2001024788A3 (en) 2001-12-06
HUP0203050A2 (hu) 2003-02-28
EP1220667B1 (en) 2004-07-28
KR100738724B1 (ko) 2007-07-12
PE20010742A1 (es) 2001-07-19
HU225990B1 (en) 2008-02-28
CN1377264A (zh) 2002-10-30
TR200200899T2 (tr) 2002-07-22
MA25501A1 (fr) 2002-07-01
CA2385974A1 (en) 2001-04-12
CA2385974C (en) 2010-01-26
JP2003510354A (ja) 2003-03-18
MXPA02003453A (es) 2002-08-20
AR028487A1 (es) 2003-05-14

Similar Documents

Publication Publication Date Title
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
PL342596A1 (en) Cross-linked starch of high amylose content and with functional group as a matrix for prolonged release pharmacological agents
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
GEP20012388B (en) Metalloproteinase Inhibitors, Pharmaceutical Compositions on Their Base, Use and Methods for Obtaining and Intermediates
GT199700009AA (es) Terapia combinada para la osteoporosis
BG103425A (en) Pharmaceutical composition
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
EP1203586A3 (en) Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin.
AR019246A1 (es) Agonistas de receptores de 5-ht1 y metoclopramida para el tratamiento de la migrana.
DK0914097T3 (da) Sammensætning og doseringsform omfattende opioid antagonist
CO5251423A1 (es) Tratamiento de endometriosis o infertilidad, o mejora de la fertilidad
GT199700037A (es) Composiciones farmaceuticas para el tratamiento de la rinitis
SE9604348D0 (sv) Användning av hydroxyguanidiner
HUP9901360A2 (hu) Cimicifuga racemosa-ból származó extraktum alkalmazása
MXPA01011606A (es) Terapia anti-inflamatoria para infeccion mediada por inflamacion.
NO20026244D0 (no) Neurobeskyttende 7-beta-hydroksysteroider
BG105277A (en) Prevention of migraine recurrence
ID16186A (id) Penggunaan baru untuk pengobatan
CO4930269A1 (es) Composiciones farmaceuticas
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
ES2159260B1 (es) Nueva composicion de metanosulfonato de paroxetina
UY25103A1 (es) Composición para el tratamiento de diabetes mellitus
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353

Legal Events

Date Code Title Description
FC Application refused